Literature DB >> 2971510

Complement in the pathophysiology and diagnosis of human diseases.

A P Dalmasso1.   

Abstract

Complement is a humoral effector system composed of 21 plasma proteins that was identified initially because of its cytolytic effects. In addition to cytolysis, complement has a number of different functions related to inflammatory and other host defense processes. The description of the reaction mechanism includes: (1) activation of the classical pathway through recognition of IgG and IgM antibodies by C1q, (2) activation of the alternative pathway which is usually achieved without participation of immunoglobulins, (3) generation of proteolytic enzymes composed of heteropolymers that cleave certain precursor proteins, (4) formation of the membrane attack complex (MAC), and (5) participation of control mechanisms. Methodologies for studying protein concentration and functional activities of complement components include not only the classical hemolytic techniques but also the extremely sensitive new radioimmunoassays and enzyme immunoassays for measuring the products of complement activation that are generated in vivo. Examples of genetically controlled complement deficiencies have been published for most complement components. The symptomatology of some of these patients serves to emphasize the protective role of complement. Acquired deficiencies are significant not only as laboratory aids in diagnosis and to evaluate the course of certain diseases, but also to indicate possible pathogenic disease mechanisms. Recently, it has been recognized that the complement proteins with genes located in the HLA region are polymorphic. Certain variants of proteins C2, C4, and factor B occur with higher frequencies in certain diseases than in the general population, which appears to be of great practical importance in laboratory medicine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2971510     DOI: 10.3109/10408368609110272

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  12 in total

1.  Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients.

Authors:  A P Dalmasso; G M Vercellotti; R J Fischel; R M Bolman; F H Bach; J L Platt
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

Review 2.  Clinical utility of complement assessment.

Authors:  A E Ahmed; J B Peter
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

3.  Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.

Authors:  Y Wang; Q Hu; J A Madri; S A Rollins; A Chodera; L A Matis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

Review 4.  Complement in Lupus Nephritis: New Perspectives.

Authors:  Lihua Bao; Patrick N Cunningham; Richard J Quigg
Journal:  Kidney Dis (Basel)       Date:  2015-06-30

Review 5.  Intertwined pathways of complement activation command the pathogenesis of lupus nephritis.

Authors:  Abhigyan Satyam; Ryo Hisada; Rhea Bhargava; Maria G Tsokos; George C Tsokos
Journal:  Transl Res       Date:  2022-03-14       Impact factor: 10.171

6.  Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).

Authors:  G A Niehans; D L Cherwitz; N A Staley; D J Knapp; A P Dalmasso
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

7.  A Bifunctional Adsorber Particle for the Removal of Hydrophobic Uremic Toxins from Whole Blood of Renal Failure Patients.

Authors:  Marieke Sternkopf; Sven Thoröe-Boveleth; Tobias Beck; Kirsten Oleschko; Ansgar Erlenkötter; Ulrich Tschulena; Sonja Steppan; Thimoteus Speer; Claudia Goettsch; Vera Jankowski; Joachim Jankowski; Heidi Noels
Journal:  Toxins (Basel)       Date:  2019-07-03       Impact factor: 4.546

Review 8.  Complement as a Therapeutic Target in Systemic Autoimmune Diseases.

Authors:  María Galindo-Izquierdo; José Luis Pablos Alvarez
Journal:  Cells       Date:  2021-01-13       Impact factor: 6.600

9.  Serum Level of Complement C1q is Associated with Contrast-Associated Acute Kidney Injury in Patients Undergoing Emergency Percutaneous Coronary Intervention.

Authors:  Jun Tao; Chenglin Ye; Wen Dai; Di Li; Man Zhou; Yan Li
Journal:  J Inflamm Res       Date:  2021-12-24

10.  Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury.

Authors:  R J Quigg; C He; A Lim; D Berthiaume; J J Alexander; D Kraus; V M Holers
Journal:  J Exp Med       Date:  1998-10-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.